[Clinical studies on the therapeutic effect of beta-mercaptoethylamine (lathyrogen) on fibrosis of the liver. II. Prevention of the development of hepatic fibrosis by use of beta-mercaptoethylamine].
D006801:Humans; D006909:Hydroxyproline / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D008624:Mercaptoethylamines / Q000008:administration & dosage / Q000627:therapeutic use*
D008624:Mercaptoethylamines; D006909:Hydroxyproline